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Abstract In recent years, the increased intake of ibuprofen
has resulted in the presence of the drug in the environment.
This work presents results of a study on degradation of ibu-
profen at 25 mg L−1 in the presence of glucose, as an addi-
tional carbon source by Bacillus thuringiensis B1(2015b). In the
cometabolic system, the maximum specific growth rate of the
bacterial strain was 0.07 ± 0.01 mg mL−1 h−1 and Ksμ
0.27 ± 0.15 mg L−1. The maximum specific ibuprofen removal
rate and the value of the half-saturation constant were
qmax = 0.24 ± 0.02 mg mL
−1 h−1 and Ks = 2.12 ± 0.56 mg L
−1,
respectively. It has been suggested that monooxygenase and cat-
echol 1,2-dioxygenase are involved in ibuprofen degradation by
B. thuringiensis B1(2015b). Toxicity studies showed that
B. thuringiensis B1(2015b) is more resistant to ibuprofen than
other tested organisms. The EC50 of ibuprofen on the B1 strain
is 809.3 mg L−1, and it is 1.5 times higher than the value of the
microbial toxic concentration (MTCavg). The obtained results
indicate that B. thuringiensis B1(2015b) could be a useful tool
in biodegradation/bioremediation processes.
Keywords Biodegradation . Biotransformation . Ibuprofen .
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Introduction
Every year, a great number of pharmaceutical compounds are
consumed, and after their partial metabolism, they enter sewage
treatment plants. However, the removal of these compounds is
not efficient, and pharmaceuticals are still observed in the sewage
treatment plant effluents, as well as in surface water, groundwater
and even drinking water (Tambosi et al. 2010). Ibuprofen, one of
the non-steroidal anti-inflammatory drugs, is the third most high-
ly consumed pharmaceutical in the world. It has been detected in
the environment at the ppt to ppb concentration range (Murdoch
and Hay 2015).
Acute and chronic toxicity studies on daphnia and fish
allowed the determination of the no observed effect concentra-
tion (NOEC) of ibuprofen, which was then used to calculate the
predicted no-effect concentration (PNEC). Because the estimated
MEC/PNEC (real risk) ratio for ibuprofen was over 1, a probable
environmental risk was suggested (Bouissou-Schurtz et al.
2014). The hitherto toxic effects of ibuprofen on Scenedesmus
subspicatus, Pseudokirchneriella subcapitata, Daphnia magna,
Daphnia longispina, Neocaridina denticulata, Danio rerio,
Pimephales notatus, Oncorhynchus mykiss, Rutilus rutilus,
Oreochromis niloticus, Oryzias latipes, Menidia beryllina and
Mytilus galloprovinciali as model organisms were evaluated
(Brozinski et al. 2013; Fent et al. 2006; Flippin et al. 2007;
Gonzalez-Naranjo and Boltes 2014; Gonzales-Rey and
Bebianno 2012; Jeffries et al. 2015; Ragugnetti et al. 2011;
Sung et al. 2014). Flippin et al. (2007) showed that ibuprofen
increased the number of eggs with a simultaneous decrease in the
number of fish spawning in Japanese medaka, Oryzias latipes.
Exposition ofMytilus galloprovincialis on ibuprofen at an envi-
ronmentally realistic concentration (250 ng L−1) confirmed the
endocrine disruption effect of this drug. Moreover, in the pres-
ence of ibuprofen, the induction of antioxidative stress was ob-
served. The activities of superoxidase dismutase, catalase,
Responsible editor: Gerald Thouand
* Danuta Wojcieszyńska
danuta.wojcieszynska@us.edu.pl
1 Department of Biochemistry, Faculty of Biology and Environmental
Protection, University of Silesia in Katowice, Jagiellońska 28,
40-032 Katowice, Poland
Environ Sci Pollut Res (2017) 24:7572–7584
DOI 10.1007/s11356-017-8372-3
glutathione reductase and phase II glutathione S-transferase in-
creased during 7 days of exposure. The increase in the lipid
peroxidation level and, in consequence, membrane damage in
the digestive gland of mussels were also observed (Gonzales-
Rey and Bebianno 2012). Jeffries et al. (2015) suggested that a
low concentration of ibuprofen, at 11.5μg L−1, causes the down-
regulation of genes involved in skeletal development, aerobic
respiration and immune function, whereas higher concentrations
of ibuprofen may increase the expression of regulatory genes
connected with the arachidonic acid metabolism pathway and
immune genes involved in an inflammatory response.
Considering all the above facts, it is important to develop the
effective methods for the removal of ibuprofen from the
environment.
The highest effectiveness of ibuprofen degradation is
reached by using the physicochemical methods, especially ad-
vanced oxidation processes (AOP) (Gongora et al. 2016;
Huang et al. 2015; Iovino et al. 2016). During the AOP, high
reactive hydroxyl radicals are generated which initiate the oxi-
dation of ibuprofen (Braz et al. 2014; Gongora et al. 2016; Li
et al. 2015). Hydratropic acid, 4-ethylbenzaldehyde, 4-(1-
carboxyethyl)benzoic acid, 1-(4-isobutylphenyl-1-ethanol,
2-[4-(1-hydroxy-2-methylpropyl)phenyl]propanoic acid, 1-
isobutyl-4-vinylbenzene, 4-isobutylphenol, 4-acetylbenzoic ac-
id and 4-isobutylacetophenon are formed in this process
(Caviglioli et al. 2002; Ruggeri et al. 2013; Sabri et al. 2012).
However, toxicity studies have shown that intermediates
formed during the AOP treatment are more toxic than the pri-
mary compound (Braz et al. 2014; Huang et al. 2015; Quero-
Pastor et al. 2014). For that reason, biological methods of ibu-
profen degradation seem to be a good alternative. There is still
little information on metabolites formed during the biodegrada-
tion of ibuprofen through activated sludge. However, Collado
et al. (2012) observed the partial degradation of ibuprofen
(<10%, 44% and 60% accounting for 10, 100 and 1000 μg/L
of ibuprofen, respectively), with the simultaneous formation of
intermediates: carboxyibuprofen and hydroxyibuprofen iso-
mers. The latter were also detected by Quintana et al. (2005).
So far, only four pure strains able to degrade ibuprofen have
been described: Nocardia sp. NRRL 5646, Sphingomonas Ibu-
2, Variovorax Ibu-1 and Patulibacter sp. I11 (Almeida et al.
2013; Chen and Rosazza 1994; Murdoch and Hay 2005;
Murdoch and Hay 2013). Degradation of ibuprofen by
Patulibacter sp. I11 was observed only in the presence
of yeast extract and tryptone. The results of quantitative
proteomic analysis suggest that acyl-CoA synthetase, a
protein containing a Rieske-like (2Fe–2S) iron–sulphur
cluster (dioxygenase-like protein), and enoyl–CoA
hydratase/isomerase may be involved in the decomposi-
tion of ibuprofen (Almeida et al. 2013). Ibuprofenol and
ibuprofenol acetate were detected during the degradation
of ibuprofen by the lignolytic bacterium Nocardia sp.
NRRL 5646 (Chen and Rosazza 1994).
Murdoch and Hay (2005, 2015) proposed the biodegrada-
tion pathway of ibuprofen in Sphingomonas Ibu-2 and
Variovorax Ibu-1. In Sphingomonas Ibu-2, the degradation
of ibuprofen occurs through isobutylcatechol as an intermedi-
ate. In the next step, isobutycatechol is cleaved to 5-formyl-2-
hydroxy-7-methylocta-2,4-dienoic acid, transformed to 2-hy-
droxy-5-isobutylhexa-2,4-dienedioic acid. In this pathway,
meta-cleavage enzymes are probably engaged (Murdoch and
Hay 2005; Murdoch and Hay 2015). The participation of
meta-ring fission enzymes in the biotransformation of ibupro-
fen by Variovorax Ibu-1 has also been suggested (Murdoch
and Hay 2015).
In the light of the above-mentioned facts and the still lim-
ited knowledge on the degradation of ibuprofen by bacteria, it
is very important to study the microbiological degradation of
ibuprofen and its impact on the environment. Therefore, the
aims of our work were to investigate the degradation of ibu-
profen by the pure bacterial strain Bacillus thuringiensis
B1(2015b) in a monosubstrate and cometabolic systems and
to identify enzymes engaged in ibuprofen transformation. We
have also evaluated the toxicity of ibuprofen to model organ-
isms and B. thuringiensis B1(2015b) and determined the in-
fluence of ibuprofen on bacterial fatty acid profiles. To our
knowledge, it is the first work which links studies leading to a
better understanding of the ibuprofen biodegradation process
and to the evaluation of the impact of this drug on the
environment.
Materials and methods
Bacterial strain and growth conditions
B. thuringiensis B1(2015b) (Marchlewicz et al. 2016) was
routinely cultivated in the nutrient broth composed of pancre-
atic digest of gelatin and beef extract (BBL® Nutrient Broth,
Becton Dickinson, USA) at 30 °C and 130 rpm for 24 h. After
this, cells were harvested by centrifugation (5000×g at 4 °C
for 15 min), washed with a fresh sterile mineral salts medium
(Greń et al. 2010, Cai et al. 2016) and used as inoculum.
Adaptation of B. thuringiensis B1(2015b) to increasing
concentration of ibuprofen
Studies on the degradation of ibuprofen were performed in
500-mL Erlenmeyer flasks containing 250mL of mineral salts
medium (Greń et al. 2010) inoculated with bacterial cells to a
final optical density of about 0.8 (OD600) for the
monosubstrate and 0.1 (OD600) for cometabolic systems.
Ibuprofen was added to each flask to obtain an initial concen-
tration of 1 and 5 mg L−1 for monosubstrate and cometabolic
systems, respectively. If the complete degradation of ibupro-
fen was observed, a successive dose of the drug was
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introduced into the culture. For the cometabolic degradation
of ibuprofen, 1000 mg L−1 glucose, 282 mg L−1 phenol,
432 mg L−1 benzoate and 417 mg L−1 4-hydroxybenzoate
were used as growth substrates. After complete degradation
of the suitable growth substrate, a successive dose of the
growth substrate was introduced into the culture. All cultures
were grown in triplicate and were incubated with shaking at
30 °C for 14 days. Bacterial growth was determined by optical
density at λ = 600 nm (OD600).
Additionally, two control cultures (250 mL each) were
prepared: an uninoculated control consisting of a mineral
salts medium and a heat-killed control consisting of a
mineral salts medium and bacterial cells destroyed by
autoclaving. The heat-killed control was used to check
the possible adsorption of ibuprofen on fragments of bac-
terial cells that may result in the decrease of the drug
concentration. The optical density of the heat-killed con-
trol was the same as for the examined cultures.
Determination of kinetic parameters of ibuprofen
degradation
To study the degradation kinetics, pure cultures of bacterial
strain were separately inoculated in a series of 500-mL
Erlenmeyer flasks containing 250 mL of the mineral salts
medium (Greń et al. 2010) supplemented with ibuprofen at
initial concentrations of 1, 3, 5, 7 and 9 mg L−1 to a final
optical density of 0.8 or 0.1 (OD600) in monosubstrate or
cometabolic systems, respectively. Based on the results of
preliminary studies (unpublished data), in cometabolic sys-
tems, glucose at a final concentration of 1 g L−1 was added
in a solution as the best co-substrate for bacterial growth dur-
ing ibuprofen degradation. The flasks were incubated with
shaking at 30 °C. Samples were taken every 3 h from the
monosubstrate and every 2 h from the cometabolic cultures.
Growth of the strain was monitored by the optical densities at
600 nm, and the degradation kinetics was studied by the mea-
surements of the residual concentration of ibuprofen in the
medium. The concentration of glucose (in cometabolic cul-
tures) was also determined.
The equation by which the death rate in the
monosubstrate culture was evaluated according to the
Gompertz model is formulated below:
y ¼ y0 þ a expbC;
where y is the death rate (mg mL−1 h−1), a is the initial
death, b is the rate of increase in death and C is the
substrate concentration (mg L−1) (Avraam et al. 2013;
Casolari 1988; Wu et al. 2008). Kinetic constants were
estimated with the exponential growth equation using
SigmaPlot 12.0 software.
To study the microbial growth in cometabolic cultures, the
Andrew model was used, which is given by the following
equation:
μ ¼ μmax  S
KSμ þ S þ S
2
Ki
 
where μ is the specific growth rate (mg mL−1 h−1), μmax is
the maximum specific growth rate (mg mL−1 h−1), Ksμ is
the substrate concentration in which μ = 1/2μmax
(mg L−1), Ki is the inhibition constant (mg L
−1) and S is
the ibuprofen concentration (mg L−1) (Gąszczak et al.
2010). Kinetic constants were est imated by the
Levenberg–Marquardt method using Statistica 10.0
software.
The Monod equation, by which the biodegradation of ibu-
profen in monosubstrate and cometabolic cultures was evalu-
ated, is formulated below:
q ¼ qmax  S
KS þ S
where q is the specific ibuprofen removal rate (mg L−1 h−1),
qmax is the maximum specific ibuprofen removal rate
(mg L−1 h−1), Ks is the half-saturation constant (mg L
−1) and
S is the ibuprofen concentration (mg L−1) (Durruty et al. 2011;
Okpokwasili and Nweke 2005). Kinetic constants were esti-
mated using SigmaPlot 12.0 software.
Determination of substrate concentration
The concentration of ibuprofen and other aromatic com-
pounds was determined with the HPLC technique using the
Merck Hitachi HPLC reversed-phase chromatograph
equipped with an Ascentis Express ® C18 HPLC Column
(100 × 4.6 mm), an Opti-Solw ® EXP pre-column and a
UV/VIS DAD detector. The mobile phase consisting of ace-
tonitrile and 1% acetic acid (70:30 v/v) at a flow rate of
1 mL min−1 was used during the analysis of the ibuprofen
concentration. For the determination of phenol, benzoate and
4-hydroxybenzoate concentration, the mobile phase
consisting of acetonitrile, methanol and 1% acetic acid
(20:20:60 v/v/v) at a flow rate of 1 mL min−1 was used. The
detection wavelengths were set at 263, 272, 272 and 260 nm
for ibuprofen, phenol, benzoate and 4-hydroxybenzoate, re-
spectively (Wojcieszyńska et al. 2014).
Ibuprofen and aromatic cosubstrates in supernatants
were identified by comparing the HPLC retention time
and UV–visible spectra with those of the external stan-
dards. The concentration of glucose in the culture su-
pernatant was determined using a colorimetric anthrone
method (Gerhardt et al. 1994).
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Bacterial growth inhibition test
To determine the inhibitory effect of ibuprofen on bacterial
growth, a pure culture of B. thuringiensis B1(2015b) was
grown in the nutrient broth supplemented with ibuprofen in
the concentration range 0–2.0 mg L−1. The initial optical den-
sity of each culture was 0.1 (OD600). After 24 h incubation
with shaking at 30 °C, the optical density of the cultures was
measured. The EC50 value was estimated using GraphPad
PRISM 6.05 software.
Toxicity bioassays
In order to assess the toxicity of ibuprofen, acute toxicity,
chronic toxicity and mutagenicity tests were performed. To
assess the acute toxicity of ibuprofen toward various microor-
ganisms, the MARA test was conducted. The assay was per-
formed using ten reference bacterial strains and one strain of
yeast, in 96-well microtitre plates in three independent trials.
For each plate, both positive (without ibuprofen) and negative
(without microorganisms) controls were included. After 18 h
of incubation in the dark at 30 °C, the plates were subjected to
image analysis. The microbial growth after exposure to the
concentration gradient of ibuprofen was determined by a re-
duction of tetrazolium salt which precipitated at the bottom of
the wells. The results were expressed as microbial toxic con-
centration (MTC) for each microorganism and for the whole
test. The MTC value was calculated according to the formula:
MTC ¼ cmin  d
Ptot
Poð Þ−1
where cmin is the lowest concentration in the gradient, PO is
the pellet size in the control, d is the dilution factor and Ptot is
the sum of all pellet sizes across the concentration gradient
(Bronowska et al. 2013; Sieroslawska 2014; Wadhia 2008).
The chronic toxicity of ibuprofen was determined with the
use of Protoxkit F (MicroBioTest Inc.) and Tetrahymena
thermophila as the test organism. The test is based on the
turnover of the substrate into the ciliate biomass.
T. thermophila was grown in the presence of the substrate
and 0.625, 1.25, 2.5, 5.0 or 10.0 mg L−1 ibuprofen at 30 °C
in the dark. After 48 h of incubation, optical density at 440 nm
was measured. The inhibition of growth of the culture was
reflected by the remaining turbidity.
Ames MPF tests (Xenometrix) were performed with
Salmonella typhimurium TA98 and S. typhimurium TA100
according to the manufacturer’s recommendations. Ten
millilitres of the growth medium was inoculated with 10 μL
of refrozen bacterial strains and incubated for 16 h at 37 °C
with shaking at 250 rpm in the presence of 50 μg mL−1 am-
picillin until culture density reached >2.0 (OD600). The obtain-
ed cultures were diluted tenfold into the exposure medium,
and 240 μL of the mixture was introduced into every well of
a 24-well plate. Simultaneously, an appropriate volume of
50 mg mL−1 ibuprofen stock solution was introduced into
the wells to obtain the final concentrations of 8, 25, 74, 222,
667 and 2000 mg L−1 of ibuprofen. Diluted inocula of bacte-
rial strains were negative controls. The positive controls com-
prised the diluted inoculum and 0.1 μg mL−1 4-
nitroquinoline-N-oxide or 2.0 μg mL−1 2-nitrofluorene as mu-
tagens. The mutagenicity assays were also conducted in the
presence of metabolic activation fraction S9 (rat liver micro-
somal fraction). The samples were prepared similarly as de-
scribed above, except that the microsomal fraction was further
introduced into each well. Diluted inocula of bacterial strains
were negative controls. The positive controls consisted of di-
luted inocula of bacteria, fraction S9 and 0.5 or 1.25 μg mL−1
2-aminoanthracene for strains TA98 and TA100, respectively.
The 24-well plates were then incubated for 90 min at 37 °C
with shaking at 250 rpm, and the cultures were mixed with the
indicator medium. Then, 50-μL aliquots of each culture were
replica plated into 48 wells of a 384-well plate and incubated
at 37 °C for 48 h. The number of positive wells out of 48 wells
per replicate and per tested concentration of ibuprofen was
compared with the number of spontaneous revertants obtained
in the negative control section (Flückiger-Isler et al. 2004).
Fatty acid extraction and analysis
The fatty acid composition of B. thuringiensis B1(2015b) was
determined after 18 h of cultivation of the strain on (1) a nutrient
broth (control sample), (2) a nutrient broth containing 0.8 g L−1
ibuprofen and (3) a nutrient broth containing 2.0 g L−1 ibupro-
fen. Bacteria were harvested by centrifugation (8000×g) at 4 °C
for 20 min. The cell pellets were washed twice with 0.85%
NaCl to remove the residue of the culture medium. The fatty
acid isolation and identification were conducted by the MIDI–
MIS method (Sasser 1990). Analysis of the fatty acid methyl
esters (FAMEs) was performed using an HP 5890 gas chro-
matograph (Hewlett Packard, Rolling Meadows, IL, USA)
equipped with an HP 25 m × 0.2 mm cross-linked methyl-
silicone capillary column. The initial oven temperature was
170 °C. Then, it was increased to 260 °C at 5 °C min−1 and
then to 320 °C at 40 °C min−1, and was held constant for
1.5 min. Helium was used as the carrier gas. FAMEs were
identified using Sherlock software (TSBA library, version 3.9,
Microbial ID, Newark, NJ, USA) based on the actual calibra-
tion retention times run prior to sample analysis.
The results were evaluated by analysis of variance. Three
replicates of data obtained from each treatment were analysed
statistically by one-way ANOVA. The statistical significance
(p < 0.05) of the differences was assessed by a post hoc com-
parison of the means using the least significant difference
(LSD) test. The FAMEs profiles were also subjected to prin-
cipal component analysis (PCA). This was performed based
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on the average values of three replicates. All analyses were
performed using the Statistica 12.0 PL software package.
Preparation of cell extracts
The cell-free extracts were prepared from the B. thuringiensis
B1(2015b) cultures grown to the OD600 <0.8. The crude ex-
tracts were isolated from monosubstrate cultures with ibupro-
fen, glucose, phenol, benzoate or 4-hydoxybenzoate as a sole
carbon source, and from cometabolic cultures with ibuprofen
as a cometabolite and glucose, phenol, benzoate or 4-
hydroxybenzoate as a growth substrate. The bacterial cells
were harvested by centrifugation (4500×g) for 15 min at
4 °C. The obtained pellets were washed with 50 mM phos-
phate buffer, pH 7.0, and resuspended in the same buffer.
Then, the whole-cell suspensions were homogenised by son-
ication (six times for 15 s) and subjected to centrifugation at
9000×g for 30 min at 4 °C. Clear supernatants were used as
crude cell extracts for the enzyme assays.
Enzyme assays
Phenol monooxygenase activity was determined spectropho-
t ome t r i c a l l y b y me a s u r i n g NADH ox i d a t i o n
(ε340 = 6220 M
−1 cm−1) (Divari et al. 2003). The activity of
catechol 1,2-dioxygenase was measured spectrophotometri-
cally by the formation of cis,cis-muconic acid at 260 nm
(ε260 = 16,800 M
−1 cm−1). In order to determine catechol
2 ,3 -d ioxygenase ac t i v i t y, t h e fo rma t i on o f 2 -
hydroxymuconic semialdehyde was measured at 375 nm
(ε375 = 36,000 M
−1 cm−1) (Wojcieszyńska et al. 2011a). The
activity of protocatechuate 3,4-dioxygenase was assayed by
measuring the oxygen consumption rate (Hou et al. 1976).
The activity of protocatechuate 4,5-dioxygenase was mea-
sured spectrophotometrically by the formation of 2-hydroxy-
4 - c a r b o x ymu c o n i c s em i a l d e h y d e a t 4 1 0 nm
(ε410 = 9700 M
−1 cm−1) (Wojcieszyńska et al. 2011a). One
unit of enzyme activity was defined as the amount of enzyme
required to generate 1 μmol of product per minute. Protein
concentration in the crude extract was determined by the
Bradford method using bovine serum albumin as a standard
(Wojcieszyńska et al. 2011a).
Results and discussion
Biodegradation studies
Bacillus species belong to Gram-positive bacteria, which are
known for their tolerance to various toxic compounds. This
results mainly from the structure of their cellular membranes
as well as from their ability to synthesise surface-active agents
and specific enzymes (Satchanska et al. 2006; Solyanikova
et al. 2014; Swaathy et al. 2014; Trivedi et al. 2011). For this
study, B. thuringiensis B1(2015b) isolated from the soil at the
Chemical Factory BOrganika-Azot^ in Jaworzno and able to
degrade ibuprofen and naproxen was used (Marchlewicz et al.
2016). The adaptation of B. thuringiensis B1(2015b) strain to
increasing concentrations of ibuprofen showed its ability to
degrade up to 5 mg L−1 of this drug. However, in the presence
of ibuprofen as a sole carbon and energy source, growth of the
culture was not observed, and consequently, the B1(2015b)
strain lost its degradation activity (Fig. 1a). It is generally
known that the introduction of an additional carbon source
to the culture may enhance the metabolism of xenobiotics.
For example, Quintana et al. (2005) showed that the degrada-
tion of 5 mg L−1 ibuprofen by activated sludge lasted for over
28 days, while in the presence of powder milk as an additional
carbon source, complete degradation of the introduced dose of
ibuprofen was observed after 22 days. In the studies on the
cometabolic degradation of ibuprofen, glucose was chosen as
an easily assimilated growth substrate. Simultaneously, as
growth substrates, phenol, benzoate and 4-hydroxybenzoate
were used. These aromatic compounds are substrates of sim-
ilar structure to ibuprofen and are known to induce synthesis
of the enzymes engaged in aromatic ring fission
(Wojcieszyńska et al. 2014). The highest rate of ibuprofen
degradation was observed in the presence glucose as the
growth substrate. Under these conditions, B1(2015b) was able
to degrade completely up to 25 mg L−1 of ibuprofen (Fig. 1b).
In turn, the addition of aromatic compounds as growth sub-
strates resulted in the decreased ability of strain B1(2015b) to
degrade ibuprofen. In the presence of these compounds,
B1(2015b) degraded only up to 5 mg L−1 of ibuprofen
(Fig. 1c, d). This may result from the competition between
aromatic growth substrates and ibuprofen for the active site
of enzymes involved in aromatic ring degradation (Wang et al.
2015). Particularly, in the presence of benzoate or 4-
hydroxybenzoate as a carbon source, degradation of ibuprofen
was ineffective. In the presence of benzoate, complete degra-
dation of 5 mg L−1 of ibuprofen was observed after 14 days of
incubation (Fig. 1d). In the presence of 4-hydroxybenzoate
after 4 days of incubation, darkening of the culture was ob-
served. At the same time, a 40.8% loss of ibuprofen and a
100% loss of 4-hydroxybenzoate were determined (data not
shown). This may suggest condensation of ibuprofen and 4-
hydroxybenzoate, as carboxylic acids are known to initiate
this kind of reaction (Stebbins et al. 2015; Wasiniak and
Lukaszewicz 2010). Additionally, the presence of the hydroxy
group in the para position of 4-hydroxybenzoate facilitates
the condensation of these compounds.
In the presence of the growth substrates, the activity of
enzymes engaged in aromatic compound metabolism was ob-
served. The activity of monooxygenase and catechol 1,2-
dioxygenase was observed in the crude extracts from each
monosubstrate culture (Table 1). The higher activity of
7576 Environ Sci Pollut Res (2017) 24:7572–7584
monooxygenase in the presence of ibuprofen, phenol and ben-
zoate reveals hydroxylation, the first step of aromatic com-
pound degradation (Wojcieszyńska et al. 2011b), while the
activity of catechol 1,2-dioxygenase indicates ortho cleavage
of the aromatic ring of these compounds (Guzik et al. 2013).
In the presence of 4-hydroxybenzoate as an inductor, the ac-
tivity of monooxygenase and catechol 1,2-dioxygenase was
significantly lower than in the control culture with glucose
(Table 1). In turn, in the presence of benzoate and 4-
hydroxybenzoate, high activity of protocatechuate 3,4-
dioxygenase was observed (Table 1). This suggests the en-
gagement of this enzyme in the degradation of the aromatic
ring of carboxylic acid. Additionally, the high activity of this
enzyme results from its induction by the product of the ring
cleavage—3-carboxy-cis,cis-muconic acid (Tropel and van
der Meer 2004).
Until now, the activity of enzymes engaged in degradation
of aromatic compounds in the presence of ibuprofen was not
described. In this study, in the cometabolic systems with ibu-
profen and benzoate or 4-hydroxybenzoate as a growth sub-
strate, the inhibition of protocatechuate 3,4-dioxygenase was
observed (Table 2). It may result from the fact that ibuprofen is
a competitive inhibitor of cyclooxygenase-2 and the arachi-
donic acid oxidative enzyme (Prusakiewicz et al. 2009),
which, similarly to protocatechuate 3,4-dioxygenase, belong
to the family of non-heme oxygenases (Abu-Omar et al. 2005;
Guzik et al. 2013). Moreover, active sites of both
cyclooxygenase-2 and protocatechuate 3,4-dioxygenase are
Table 1 Specific activity of
enzymes in monosubstrate
cultures
Enzyme Specific enzyme activity (U mg−1 protein)
IBU GLC PH BS 4-HB
Monooxygenase 20.64 ± 1.05 19.68 ± 1.50 21.29 ± 1.72 20.27 ± 0.79 8.80 ± 0.98
Catechol
1,2-dioxygenase
56.29 ± 0.72 41.31 ± 3.77 199.10 ± 10.24 35.16 ± 5.21 16.60 ± 1.82
Catechol
2,3-dioxygenase
0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Protocatechuate
3,4-dioxygenase
0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 392.71 ± 0.0 7724.2 ± 0.0
Protocatechuate
4,5-dioxygenase
0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 5.30 ± 1.07 0.0 ± 0.0
IBU ibuprofen, GLC glucose, PH phenol, BS benzoate, 4-HB 4-hydroxybenzoate
Fig. 1 Biodegradation of
ibuprofen by Bacillus
thuringiensis B1(2015b) in
monosubstrate (a) and
cometabolic systems with glucose
(b), phenol (c) and benzoate (d) as
growth substrates
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long hydrophobic channels with a number of basic amino acid
residues (e.g. arginine). It is suggested that the carboxylic
group of ibuprofen forms a salt bridge with the guanidinium
group of arginine and blocks the entrance into the active site of
cyclooxygenase (Dannhardt and Kiefer 2001). We assume
that ibuprofen interacts with arginine residues of the hydro-
phobic channel of protocatechuate 3,4-dioxygenase in the
same manner and inhibits the enzyme. The lack of inhibitory
effect of ibuprofen on catechol 1,2-dioxygenase, which also
belongs to the family of non-heme oxygenases, may result
from the distinct structure of the entrance to the active site of
this enzyme (Guzik et al. 2013).
Kinetic models of ibuprofen degradation
Despite the large amount of information about degradation of
ibuprofen by the pure bacterial culture or microbial consortia,
the kinetic model of ibuprofen degradation by the pure bacte-
rial strain has not been described. For that reason, kinetic
analysis of ibuprofen degradation by B. thuringiensis
B1(2015b) was performed in monosubstrate or cometabolic
systems with glucose as a growth substrate. The dependence
of the specific ibuprofen removal rate on the ibuprofen con-
centration in monosubstrate and cometabolic systems is
shown in panels a and c of Fig. 2, respectively. The half-
saturation constant (Ks) and the maximum specific ibuprofen
removal rate (qmax) were higher for the cometabolic system
(Ks = 2.12 ± 0.56 mg L
−1; qmax = 0.24 ± 0.02 mg L
−1 h−1) than
for the monosubstrate system (Ks = 0.68 ± 0.08 mg L
−1;
qmax = 0.09 ± 0.00 mg L
−1 h−1). The half-saturation constant
expresses a bacterial affinity for a substrate (Kim et al. 2003).
Therefore, the lowerKs obtained for the monosubstrate system
suggests that B. thuringiensis B1(2015b) is able to degrade
ibuprofen faster at lower concentrations. The obtained results
also showed that the introduction of an additional carbon
source has a positive effect on ibuprofen degradation by
B. thuringiensis B1(2015b). The increased degradation of a
xenobiotic compound in the presence of an additional growth
substrate was observed by Durruty et al. (2011). In their work,
the simultaneous degradation of various chlorophenols was a
key factor improving the degradation of pentachlorophenol
(Durruty et al. 2011). The inhibitory effect of the substrate
on its degradation is frequently observed. For example,
Sinha et al. (2011) described the inhibition of degradation by
the substrate during cultivation of Rhodococcus sp. RSP8 in
the presence of phenol or p-chlorophenol. During our studies
on degradation of ibuprofen by strain B1(2015b) in both
monosubstrate and cometabolic cultures, the inhibition of this
process by the substrate was also observed. In the
monosubstrate system, inhibition was observed at a lower
concentration of ibuprofen (6 mg L−1) than in the cometabolic
system (9 mg L−1) (Fig. 2a, c). This was likely caused by
bacterial cell death observed in the monosubstrate system
(Fig. 2b). The initial death rate of 0.0003 ± 0.0002 increased
to 0.44 ± 0.07. The kinetics of microbial death indicates that
ibuprofen is an insufficient carbon source for bacteria. In turn,
in the cometabolic system, the growth of bacterial cells was
observed (Fig. 2d). In the presence of glucose as an additional
carbon source, the maximum specific growth rate was
0.07 ± 0.01 mg mL−1 h−1, Ksμ was 0.27 ± 0.15 mg L
−1 and
Ki was 137.16 mg L
−1. The increase of the maximum specific
ibuprofen removal rate in the cometabolic system results from
the high microbial biomass. In turn, the high half-saturation
constant observed under cometabolic conditions may be con-
nected with the competition between enzymes involved in
ibuprofen degradation and those engaged in glucose metabo-
lism for the cofactors.
Toxicity of ibuprofen
Ibuprofen is known to induce changes in the functioning of sev-
eral physiological systems of different organisms, probably
through the inhibition of prostaglandin synthesis. For example,
in mussels, Mytilus galloprovincialis, in the presence of ibupro-
fen, reproductive fitness impairment was observed (Gonzales-
Rey and Bebianno 2012). Evaluation of the acute toxicity of
ibuprofen showed different responses of tested strains. The most
sensitive microorganism wasDelftia acidovorans. The MTC for
this strain was 311.5 ± 84.15 mg L−1, whereas the most durable
strains were Pseudomonas aurantiaca and Serratia rubidaea
(MTC above 2000 mg L−1) (Fig. 3). The mean value of the
microbial toxic concentration MTCavg, which is the equivalent
Table 2 Specific activity of
enzymes in cometabolic cultures Enzyme Specific enzyme activity (U mg
−1 protein)
IBU + GLC IBU + PH IBU + BS IBU + 4-HB
Monooxygenase 41.27 ± 1.34 17.92 ± 0.43 18.81 ± 1.91 39.43 ± 0.52
Catechol 1,2-dioxygenase 44.22 ± 1.15 97.40 ± 1.82 40.37 ± 5.58 68.17 ± 4.46
Catechol 2,3-dioxygenase 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0
Protocatechuate 3,4-dioxygenase 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 2212.90 ± 136.07
Protocatechuate 4,5-dioxygenase 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 10.89 ± 0.50
IBU ibuprofen, GLC glucose, PH phenol, BS benzoate, 4-HB 4-hydroxybenzoate
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of EC50, was 545.50 ± 7.78 mg L
−1. EC50 estimated for
B. thuringiensis B1(2015b) grown in a nutrient broth supple-
mented with ibuprofen at a concentration range from 0 to
2.0 mg L−1 was 809.3 mg L−1 (Fig. 4). According to EU
Directive 93/67/EEC, chemical substances are classified into dif-
ferent risk classes on the basis of the lowest measured EC50.
Compounds with an EC50 ≤ 1 mg L−1 (class 1) are considered
to be very toxic to aquatic organisms. Substances with an EC50
above 1 mg L−1 and below 10 mg L−1 are toxic to aquatic
organisms, and those with an EC50 above 10 mg L
−1 but below
100 mg L−1 are considered as harmful to aquatic organisms.
Substances with an EC50 > 100 mg L
−1 are recognised as non-
toxic (Cleuvers 2004; Ortiz de Garcia et al. 2014). The determi-
nation of the toxic effect of ibuprofen on various organisms with
the use of MARA and inhibition growth (Protoxkit F) tests
showed that ibuprofen is non-toxic to aquatic organisms (Fig. 3
and Fig. 4). Moreover, the very low (a = 0.0003) initial death
parameter, which determines the death rate, estimated for
B. thuringiensis B1(2015b) grown in the presence of different
concentrations of ibuprofen also indicates the low toxicity of
ibuprofen. Therefore, various coincidence parameters (EC50
Fig. 2 Kinetic models of
ibuprofen degradation (a) and
bacterial survival (b) in the
monosubstrate system and
ibuprofen degradation (c) and
bacterial growth (d) in the
cometabolic system with glucose
as a growth substrate. The data
points represent the average of
three independent experiments
Fig. 3 Mean MTC values in the MARA test; ibuprofen exposition
ranged between 63 and 2000 mg L−1. Microorganisms used in the
MARA test: 1 Microbacterium sp. G(+), 2 Brevundimonas diminuta
G(−), 3 Citrobacter freudii G(−), 4 Comamonas testosteroni G(−), 5
Enterococcus casseliflavus G(+), 6 Delftia acidovorans G(−), 7 Kurthia
gibsonii G(+), 8 Staphylococcus warneri G(+), 9 Pseudomonas
aurantiaca G(−), 10 Serratia rubidaea G(−), 11 Pichia anomala (yeast)
Fig. 4 Inhibition of Bacillus thuringiensis B1(2015b) growth in the
presence of ibuprofen at various concentrations
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and a) may be interchangeably used for the evaluation of the
toxicity of xenobiotics.
Toxic compounds can interact with the cell membranes of
bacteria and influence their integrity and fluidity (Murínova
and Dercová 2013; Segura et al. 2010). Ibuprofen as a stressor,
due to its amphipathic features, shows high affinity to the
phospholipid bilayer of bacteria. Therefore, it was very inter-
esting to evaluate whether the high resistance of
B. thuringiensis B1(2015b) to ibuprofen was connected with
changes in the membrane fatty acid composition. The whole
cell-derived fatty acid profiles of strain B1(2015) grown in a
nutrient broth supplemented with 0.8 or 2.0 g L−1 ibuprofen
Fig. 5 a Relative proportions of fatty acids in Bacillus thuringiensis
B1(2015b) grown on nutrient broth (1), nutrient broth supplemented
with 0.8 g L−1 ibuprofen (2) and nutrient broth supplemented with
2.0 g L−1 ibuprofen (3). Class of hydroxyl fatty acids additionally
contains branched hydroxyl fatty acids. Different letters indicate a
statistically significant difference between fatty acid groups. b
Configuration of points representing the fatty acids in the system of the
first two factorial axes (principal components). c Principal component
analysis of fatty acid proportion in Bacillus thuringiensis B1(2015b)
grown on nutrient broth with the addition of ibuprofen
Table 3 Percentage of total fatty acids from Bacillus thuringiensis B1
grown on nutrient broth (1), nutrient broth supplemented with 0.8 g L−1
ibuprofen (2) and nutrient broth supplemented with 2.0 g L−1 ibuprofen
(3). Data represent the average of three independent trials ± standard
deviation
Fatty acids % of total fatty acids
1 2 3
Saturated
12:0 0.14 ± 0.03 0.00 ± 0.00 0.00 ± 0.00
14:0 1.05 ± 0.00 0.66 ± 0.07 0.51 ± 0.06
16:0 6.76 ± 0.06 5.79 ± 0.09 8.68 ± 0.34
16:0 2OH 0.34 ± 0.05 0.25 ± 0.07 0.17 ± 0.00
17:0 0.11 ± 0.00 0.06 ± 0.08 0.15 ± 0.03
18:0 1.14 ± 0.08 0.62 ± 0.05 1.26 ± 0.15
18:0 2OH 0.29 ± 0.04 0.19 ± 0.00 0.17 ± 0.02
18:0 anteiso 30.80 ± 1.55 34.01 ± 0.55 38.87 ± 1.55
Unsaturated
16:1ω7c 1.71 ± 0.22 1.61 ± 0.07 1.06 ± 0.13
16:1ω9c 0.09 ± 0.00 0.20 ± 0.01 0.00 ± 0.00
17:1ω8c 0.65 ± 0.00 0.72 ± 0.00 0.54 ± 0.00
18:1ω9c 56.88 ± 1.09 55.65 ± 0.43 48.48 ± 1.59
19:1ω11c 0.07 ± 0.09 0.15 ± 0.02 0.12 ± 0.01
20:1ω9c 0.00 ± 0.00 0.10 ± 0.14 0.00 ± 0.00
Sat./unsat. ratio 0.68 ± 0.04 0.71 ± 0.01 0.99 ± 0.07
ω methyl end of fatty acid; c cis configuration of the double bond; –OH
indicates the position of the hydroxyl group from the acid end; iso,
anteiso branched fatty acids
Table 4 Optical density at 440 nm and estimation of EC50 with
Protoxkit F
Ibuprofen
concentration,
mg L−1
ODT0 ± SD ODT48 ± SD %
inhibition
EC50,
mg L−1
0 0.503 ± 0.037 0.293 ± 0.022 0.000 17.882
0.625 0.531 ± 0.005 0.331 ± 0.014 5.000
1.25 0.521 ± 0.016 0.335 ± 0.033 11.667
2.5 0.541 ± 0.015 0.384 ± 0.028 25.238
5.0 0.521 ± 0.008 0.392 ± 0.018 38.571
10.0 0.530 ± 0.012 0.399 ± 0.006 37.857
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and in nutrient broth as the control were compared. 0.8 g L−1
ibuprofen was used as the concentration equal to the EC50
value, while 2.0 mg L−1 ibuprofen was the concentration at
which maximal growth inhibition was observed. Identified
fatty acids were divided into two groups: saturated and unsat-
urated fatty acids. Saturated fatty acids were additionally di-
vided into straight-chain, branched and hydroxy fatty acids
(Fig. 5a). The obtained results clearly showed that both the
presence of ibuprofen and its concentration alter the fatty acid
composition of B. thuringiensis B1(2015b). The FAMEs pro-
file of strain B1(2015b) grown in the presence of 0.8 g L−1
ibuprofen was distinct from others regarding factor 2.
However, the contribution of fatty acids discriminating this
profile (16:1 ω9c, 17:1 ω8c and 19:1 ω11c) was low
(Table 3). In the presence of 2.0 g L−1 ibuprofen, a high con-
tent of branched fatty acids and a low content of unsaturated
fatty acids were identified (Fig. 5a). Principal component anal-
ysis of the identified fatty acids revealed that the crucial
branched fatty acid was 18:0 anteiso, and the unsaturated fatty
acid was 18:1 ω9c (Fig. 5b, c). The increased content of
branched fatty acids together with the high content of long-
chain fatty acids in bacterial membranes modulates their flu-
idity through the increase of the phase transition temperature,
which causes the decrease of membrane permeability
(Lindström et al. 2006). The high content of branched fatty
acids determined in B. thuringiensis B1(2015b) grown in the
presence of ibuprofen at a concentration of 2.0 g L−1 may
result from their synthesis de novo (López-Lara and Geiger
2010). The increased contribution of anteiso branched fatty
acids in Gram-positive Arthrobacter chlorophenolicus A6
grown in the presence of phenol, 4-chlorophenol and 4-
nitrophenol was also observed. Additionally, these aromatic
compounds altered the ratio of anteiso/iso fatty acids (Unell
et al. 2007). In our studies the iso branched fatty acids were
not detected. The changes in the ratio of branched and unsat-
urated fatty acids of strain B1(2015b) may increase the tight-
ness of bacterial membranes, which can in turn be the adaptive
feature of the bacterium to grow in the presence of ibuprofen.
The results of the acute toxicity tests of ibuprofen do not
rule out its chronic toxic effect on organisms. It is suggested
that the chronic effects of ibuprofen on organisms is connected
with its influence on eicosanoid pathways, which are similar
in non-insect invertebrates and vertebrates (Pounds et al.
2008). The effects of chronic exposure of Menidia beryllina on
ibuprofen were described by Jeffries et al. (2015). In our studies,
the chronic effect of ibuprofen to ciliate T. thermophila was de-
termined with the use of the Protoxkit F test. The results of
toxicity tests showed that ibuprofen at the two highest concen-
trations causes the inhibition ofT. thermophila growth of approx-
imately 38% in comparison with the control (Table 4). The EC50
estimatedwith the use of Protoxkit Fwas 17.882mgL−1. Longer
exposition of the ciliate to ibuprofen at a lower concentration
revealed its toxic effects on this organism.Ta
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The mutagenic potential of ibuprofen was also studied. The
results of the mutagenicity assays presented in Table 5 indicate
that no significant increase in the number of revertant colonies
was observed. According to the EPA and GenPharmTox
guidelines, the over twofold increase in mutant frequency in
the same experiment indicates the mutagenic potential of the
compound (Lah et al. 2005). In our study, similarly to
Philipose et al. (1997), no mutagenic activity of ibuprofen
was demonstrated in tests with Salmonella strains (Table 5).
The performed studies showed the low toxicity of ibuprofen
toward tested organisms and no mutagenic activity of this drug.
However, ibuprofen may indirectly influence processes regulat-
ed by prostaglandins, which are the key regulators of reproduc-
tive processes (ovulation, implantation, menstruation), and in-
flammation processes, pain sensation, sleep and allergy (Jabbour
and Sales 2004; Zhou et al. 2010). The inhibition of prostaglan-
din synthetase activity by ibuprofen may disturb the above-
mentioned processes in non-insect invertebrates and vertebrates.
In conclusion, B. thuringiensis B1(2015b) is able to de-
grade ibuprofen both in monosubstrate and cometabolic sys-
tems. However, ibuprofen is not a sufficient carbon source for
this strain. The effective degradation of this drug occurs in the
presence of glucose. Toxicity studies showed that ibuprofen
has an EC50 for the B1(2015b) strain of 809.3 mg L
−1, and it is
higher than the microbial toxic concentration MTCavg
(545.50 ± 7.78 mg L−1). This indicates that the examined
strain is resistant to ibuprofen. The above-mentioned features
of B. thuringiensisB1(2015b) suggest the possibility of its use
in bioremediation processes.
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